Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Governance topic

No spam. Unsubscribe anytime.

Votes at a glance — CCB meeting, June 18, 2026

Cannabis Compliance Board (CCB) · June 18, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Summary of motions and outcomes from the Cannabis Compliance Board meeting on June 18, 2026: consent agenda approved; extensions, MSAs and multiple transfers of interest granted; waiver maintained with conditions; and the board adopted the LCB R152‑24 regulatory package.

Here are the formal actions recorded on the CCB June 18, 2026 agenda and the outcomes as stated on the record.

• Consent agenda (Items 2A–C): Approved. Chair moved to approve and the motion was seconded.

• Item 3 — Status checks for Clark NMSD LLC and Clark Natural Medicinal Solutions LLC (transfer of interest deadlines): The board granted extensions and set written status report deadlines (Aug 3, Oct 5, Dec 7, 2026) and continued status checks to the December 17, 2026 meeting.

• Item 4 — Three‑month status update: TRNVP098 LLC (Lander County provisional dispensary): No action required; the board agreed to place a status check on the August agenda.

• Item 5 — Management services agreement (Las Vegas Wellness & Compassion LLC / Sunset Investment Facility, MSA #26‑1): Approved.

• Item 6A — Transfer of interest: Libra Wellness Center LLC (TOI 25‑7): Approved on the record after public comment; minority owners asked for a continuance which the board declined to grant.

• Item 6B–6D — Additional transfers of interest (internal consolidations and return of license): The board approved the requested TOIs for Nevada Natural Medicines LLC and Nevada Holistic Medicine LLC (internal transfers/waivers), Clear River LLC (partial ownership transfer to KJ Universal Real Estate Investments LLC with a waiver), and SSACD1 returning license D060 to 5C Investments LLC.

• Item 7 — Closed session (NRS): Executive session was convened and returned; no open‑session deliberations from closed session were discussed.

• Item 8 — Waiver review for Trevor Giles Adamson (NRS 678B): The board kept the previously granted exemption in place but added conditions requiring a medical card to be produced within 30 days and a letter from the employer.

• Item 9 — Notice of intent to adopt permanent regulations (LCB file R152‑24‑RP1): Adopted by voice vote; board retained the 20‑gram usable sample provision after debate about sample size and incorporation of external standards.

Several items included public comments and requests for additional staff guidance. Where minority owners or public commenters raised concerns (for example, the Libra transfer or the labs’ objections to incorporation by reference), the board recorded those concerns in the meeting minutes and staff indicated follow‑up steps such as publishing referenced standards and offering guidance to licensees.

If you rely on a specific motion for legal or administrative purposes, consult the official CCB minute record and staff files; the summary above follows the actions and motions reported on the public record during the June 18 meeting.